Corbus Pharmaceuticals
CRBP
CRBP
107 hedge funds and large institutions have $120M invested in Corbus Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 22 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 100 → 107 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.12% less ownership
Funds ownership: 75.45% → 72.33% (-3.1%)
Holders
107
Holding in Top 10
1
Calls
$3.94M
Puts
$469K
Top Buyers
| 1 | +$3.7M | |
| 2 | +$1.18M | |
| 3 | +$889K | |
| 4 |
PAP
Persistent Asset Partners
Hong Kong
|
+$881K |
| 5 |
EAM
Exome Asset Management
New York
|
+$796K |
Top Sellers
| 1 | -$7.77M | |
| 2 | -$1.45M | |
| 3 | -$1.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$978K |
| 5 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
-$873K |
